Further to its intimation dated September 24, 2024, Biocon has informed that it attached press release dated October 03, 2024, titled ‘Biocon Biologics Refinances USD 1.1 Billion (INR 93,468 million) Long Term Debt through USD Bonds and New Syndicated Facility’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.